Latest News & Features
Americas
Pfizer has filed a motion to exclude a declaration and testimony supporting a class of direct purchasers that have accused it of anti-competitive conduct. 29 May 2017
Americas
Biogen has asked the US District Court for the Eastern District of California to dismiss a competition complaint filed by biotech company Ixchel Pharma. 26 May 2017
Americas
A heart valve patent owned by the University of Maryland, Baltimore, is immune to inter partes review, according to the Patent Trial and Appeal Board. 25 May 2017
Africa
The World Intellectual Property Organization’s Re:Search has launched a new five-year guide to its activities in the fight against neglected tropical diseases, malaria and tuberculosis. 24 May 2017
Biotechnology
The UK Competition and Markets Authority has provisionally decided that Merck Sharp & Dohme operated an anti-competitive discount scheme for its drug Remicade. 24 May 2017
Americas
The US Court of Appeals for the Federal Circuit partly affirmed a preliminary injunction against India-based Aurobindo Pharma last week. 24 May 2017
Americas
A district court has ordered Roxane Laboratories to pay Camber Pharmaceuticals and InvaGen Pharmaceuticals $2.3 million in attorneys’ fees. 23 May 2017
Americas
Pharmaceutical company United Therapeutics and Eli Lilly have extended and amended a nearly decade-long licence agreement covering Adcirca. 23 May 2017
Big Pharma
Pharmaceutical company Recordati has paid AstraZeneca $300 million for the European commercial rights to beta-blockers. 22 May 2017
Americas
AbbVie has lost in an inter partes review (IPR) of its rheumatoid arthritis drug Humira. 19 May 2017